To include your compound in the COVID-19 Resource Center, submit it here.

HyQvia Ig infusion 10% regulatory update

FDA approved a BLA from Baxter for subcutaneous HyQvia Ig infusion 10% to treat primary immunodeficiency in adults.

Read the full 180 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE